These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8303624)

  • 41. The effect of Cys LT1 receptor blockade on airway responses to allergen.
    Hendeles L; Davison D; Harman E; Sherman JM
    Pharmacotherapy; 1999 Nov; 19(11):1243-51. PubMed ID: 10555930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
    Evans DJ; Barnes PJ; Spaethe SM; van Alstyne EL; Mitchell MI; O'Connor BJ
    Thorax; 1996 Dec; 51(12):1178-84. PubMed ID: 8994512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of RG 12525, a new leukotriene antagonist, on pulmonary function of asthmatic adults.
    Welch MJ; Nelson HS; Paull BR; Smith JA; Feiss G; Tobey RE
    Ann Allergy; 1994 Apr; 72(4):348-52. PubMed ID: 8154635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.
    Gao JM; Cai F; Peng M; Ma Y; Wang B
    Chin Med J (Engl); 2013 Jun; 126(12):2229-34. PubMed ID: 23786930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078.
    Yamamoto H; Nagata M; Kuramitsu K; Tabe K; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
    Am J Respir Crit Care Med; 1994 Jul; 150(1):254-7. PubMed ID: 8025759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
    Wong WS; Zhu H; Liao W
    Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P; Armetti L; Gambaro G; Pieroni MG; Refini RM; Sala A; Vaghi A; Folco GC; Bianco S; Robuschi M
    Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
    Weir DC; Burge PS
    Thorax; 1993 Apr; 48(4):309-16. PubMed ID: 8511727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
    Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
    Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.
    Dockhorn RJ; Baumgartner RA; Leff JA; Noonan M; Vandormael K; Stricker W; Weinland DE; Reiss TF
    Thorax; 2000 Apr; 55(4):260-5. PubMed ID: 10722763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.
    Kraft M; Cairns CB; Ellison MC; Pak J; Irvin C; Wenzel S
    Chest; 2006 Dec; 130(6):1726-32. PubMed ID: 17166989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Peptidoleukotriene receptor antagonists in asthma therapy].
    Sakakibara H; Hirose K; Okawara S
    Nihon Rinsho; 1996 Nov; 54(11):3049-55. PubMed ID: 8950953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
    Vaquerizo MJ; Casan P; Castillo J; Perpiña M; Sanchis J; Sobradillo V; Valencia A; Verea H; Viejo JL; Villasante C; Gonzalez-Esteban J; Picado C;
    Thorax; 2003 Mar; 58(3):204-10. PubMed ID: 12612294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I; Woodcock A; Parker D; Rice L;
    Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects.
    Mulder A; Gauvreau GM; Watson RM; O'byrne PM
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1562-7. PubMed ID: 10228127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
    Rabinovitch N; Zhang L; Gelfand EW
    J Allergy Clin Immunol; 2006 Sep; 118(3):635-40. PubMed ID: 16950282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacodynamic properties of leukotriene receptor antagonists.
    Nicosia S
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.